Blog
Search the Blog
Questions Answered About the SEC Whistleblower Program
Are you aware of the SEC Whistleblower Program? Are you a whistleblower who has information about potential fraud? If so, you may be eligible to receive a financial reward under the program. What is the SEC Whistleblower Program? The Securities and Exchange Commission (SEC) whistleblower program was created to help protect investors from fraud and
Qui Tam Recoveries Reach $2.2 Billion For 2022
The Department of Justice (DOJ) recently released a press release regarding qui tam settlements in the fiscal year 2022. Qui tam is a law that allows people to sue on behalf of the government to recover funds that have been wrongfully obtained by fraud. The False Claims Act is the most commonly used qui tam
Rewards In Whistleblower Lawsuits
Whistleblowers play an important role in protecting the public from fraud and abuse of government funds. The False Claims Act (FCA) is a federal law that rewards whistleblowers who come forward with information about fraud against the government. The FCA allows whistleblowers to file qui tam lawsuits on behalf of the government and to receive a
Questions Answered About The Elmiron Lawsuits
Elmiron Lawsuits, Macular Degeneration & How Elmiron May Cause Eye Damage As the number of Elmiron lawsuits continues to grow, many are wondering if this commonly prescribed drug is linked to macular degeneration and other eye problems. A growing number of people are reporting vision issues after taking Elmiron, and there is now evidence that
What Is Unbundling Fraud For Whistleblowers
Medicare fraud is a serious and growing problem that has led to the government losing billions of dollars every year, and whistleblowers are essential in the fight against it. Unbundling fraud is one of the most common types of Medicare fraud and whistleblowers can help to stop it. In this blog post, we’ll look at
Stark Law and Anti-KickBack Differences For Whistleblowers
The Anti–Kickback Statute and the Stark Law are two important pieces of legislation that are designed to protect patients from fraudulent medical practices and protect taxpayer dollars from being wasted on unnecessary medical care. While these two laws have similar goals, they are actually quite distinct and have different implications for medicare fraud enforcement and the
Pharmaceutical Qui Tam Cases On The Rise
As the cost of healthcare continues to rise, the government is taking a closer look at pharmaceutical companies that are engaging in Medicare fraud. Pharmaceutical Medicare fraud occurs when a pharmaceutical company or its representatives attempt to defraud the government by overcharging for drugs, upcoding, or submitting false claims. Pharmaceutical companies are particularly vulnerable to misuse of Medicare funds or false claims
Jacob Tubbs Cited By NPR About Fraudulent Hospital Admissions
Not all patients who are in the ER are admitted, and it is important that those that require in-patient levels of care are treated properly in the ER setting, but recent studies have shown that some for-profit hospital chains enact practices whereby they use quotas or incentives to fraudulently admit patients for inpatient care where
Medical Testing Fraud Draws Increasing Scrutiny from DOJ in Recent Whistleblower Cases
Over the previous months, the United States has intervened in multiple whistleblower cases involving unnecessary medical testing conducted by clinical laboratories and health care providers in several states. These cases demonstrate not only the increased scrutiny with which the DOJ has approached medical testing fraud under the False Claims Act (FCA) but also the vital
Looking Back: Important Qui Tam Cases From 2021
The Department of Justice (DOJ) recently released its 2021 False Claims Act (FCA) statistics. A near-record year, the DOJ reported over $5.6 billion recovered in FCA settlements and judgments.
The DOJ’s year-end review presents an excellent opportunity to look back to some of 2021’s most notable FCA cases brought by whistleblowers.